Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India
- PMID: 28414093
- DOI: 10.1016/j.gene.2017.04.021
Imbalance in leptin-adiponectin levels and leptin receptor expression as chief contributors to triple negative breast cancer progression in Northeast India
Abstract
Background: Triple-Negative breast cancer (TNBC), accounts for a large percentage of breast cancer cases in India including Northeast India. TNBC has an unclear molecular aetiology and hence limited targeted therapies. Human breast is comprised of glandular, ductal, connective, and adipose tissues. Adipose tissue is composed of adipocytes. The adipocytes apart from being energy storage depots, are also active sources of adipocytokines and/or adipokines. The role of adipokines in breast cancer including TNBC has been sporadically documented. Two adipokines in particular, leptin and adiponectin, have come to be recognized for their influence on breast cancer risk and tumour biology. Therefore, the aim of this study was to understand the association of differential expression of critical adipokines and associated cellular mechanism in the susceptibility and severity of TNBC in northeast Indian population.
Materials and methods: We collected 68 TNBC and 63 controls cases and examined for serum leptin and adiponectin levels using enzyme linked immunosorbent assay (ELISA). Leptin Receptor (Ob-R) mRNA expression was determined by real-time polymerase chain reaction (RT-PCR) assay. Differential Ob-R mRNA expression and correlation with cancer stem cell (CSC) markers was evaluated, and correlated with severity.
Results: The serum leptin levels were significantly associated with TNBC severity, while the adiponectin levels were comparative. The serum leptin levels correlated inversely with the adiponetin levels. Serum leptin levels were unaffected with difference in parity. The difference in leptin levels in pre and post menopausal cases were found to be statistically non-significant. Higher leptin levels were also found to be associated obesity, mortality and recurrence. Obesity was found to be a factor for TNBC pathogenesis and severity. Increased Ob-R mRNA expression was associated with TNBC, significantly with TNBC severity, and was significantly higher in obese patients with higher grade TNBC cases. The Ob-R gene mRNA expression was significantly higher in the obese TNBC cases showing recurrence or mortality. The higher Ob-R gene mRNA expression correlated significantly with higher serum leptin levels and lower serum adiponectin levels in TNBC cases. The Ob-R mRNA expression with associated with modulation of CSC oct4 and nanog.
Conclusions: In conclusion, the present study is first of its kind on TNBC from northeast India, indicates that adipocytokines does play a role in TNBC pathogenesis. Thus, the understanding of molecular mechanisms of both leptin and adiponectin and their interplay in TNBC offer the prospects for new therapeutic approaches targeting similar signalling pathways.
Keywords: Adiponectin; Cancer stem cell; Leptin; Leptin receptor; Triple negative breast cancer.
Copyright © 2017 Elsevier B.V. All rights reserved.
Similar articles
-
Involvement of adiponectin and leptin in breast cancer: clinical and in vitro studies.Endocr Relat Cancer. 2009 Dec;16(4):1197-210. doi: 10.1677/ERC-09-0043. Epub 2009 Aug 6. Endocr Relat Cancer. 2009. PMID: 19661131
-
Clinicopathological and immunohistochemical characteristics of breast cancer patients from Northeast India with special reference to triple negative breast cancer: A prospective study.Curr Probl Cancer. 2020 Oct;44(5):100556. doi: 10.1016/j.currproblcancer.2020.100556. Epub 2020 Feb 3. Curr Probl Cancer. 2020. PMID: 32044043
-
Influence of the metabolic syndrome on leptin and leptin receptor in breast cancer.Mol Carcinog. 2011 Aug;50(8):643-51. doi: 10.1002/mc.20764. Epub 2011 May 13. Mol Carcinog. 2011. PMID: 21574190
-
Targeting CSC in a Most Aggressive Subtype of Breast Cancer TNBC.Adv Exp Med Biol. 2019;1152:311-334. doi: 10.1007/978-3-030-20301-6_17. Adv Exp Med Biol. 2019. PMID: 31456192 Review.
-
Alarming Burden of Triple-Negative Breast Cancer in India.Clin Breast Cancer. 2018 Jun;18(3):e393-e399. doi: 10.1016/j.clbc.2017.07.013. Epub 2017 Jul 20. Clin Breast Cancer. 2018. PMID: 28801156 Review.
Cited by
-
Adipocytokines and Insulin Resistance: Their Role as Benign Breast Disease and Breast Cancer Risk Factors in a High-Prevalence Overweight-Obesity Group of Women over 40 Years Old.Int J Environ Res Public Health. 2022 May 17;19(10):6093. doi: 10.3390/ijerph19106093. Int J Environ Res Public Health. 2022. PMID: 35627631 Free PMC article.
-
The relation between excess adiposity and breast cancer in women: Clinical implications and management.Crit Rev Oncol Hematol. 2024 Jan;193:104213. doi: 10.1016/j.critrevonc.2023.104213. Epub 2023 Nov 24. Crit Rev Oncol Hematol. 2024. PMID: 38008197 Free PMC article. Review.
-
Obesity and Cancer Metastasis: Molecular and Translational Perspectives.Cancers (Basel). 2020 Dec 16;12(12):3798. doi: 10.3390/cancers12123798. Cancers (Basel). 2020. PMID: 33339340 Free PMC article. Review.
-
Leptin and Cancer: Updated Functional Roles in Carcinogenesis, Therapeutic Niches, and Developments.Int J Mol Sci. 2021 Mar 11;22(6):2870. doi: 10.3390/ijms22062870. Int J Mol Sci. 2021. PMID: 33799880 Free PMC article. Review.
-
Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome.Breast Cancer Res Treat. 2019 Aug;177(1):77-91. doi: 10.1007/s10549-019-05307-8. Epub 2019 Jun 4. Breast Cancer Res Treat. 2019. PMID: 31165373 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous